United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

organon pharma (uk) ltd - benzatropine mesilate - oral tablet - 2mg

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - benzatropine mesilate 2mg (2.04mg includes 2% overage) - tablet - 2 mg - active: benzatropine mesilate 2mg (2.04mg includes 2% overage) excipient: calcium hydrogen phosphate dihydrate lactose monohydrate magnesium stearate maize starch powdered cellulose

Canada - English - Health Canada

merck frosst canada & cie, merck frosst canada & co. - benztropine mesylate - tablet - 2mg - benztropine mesylate 2mg - anticholinergic agents

New Zealand - English - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - benzatropine mesilate 1 mg/ml - solution for injection - 2 mg/2ml - active: benzatropine mesilate 1 mg/ml excipient: sodium chloride water for injection - cogentin is recommended for all forms of parkinsonism including arteriosclerotic, postencephalitic, idiopathic, as well as medicine-induced extrapyramidal disorders (except tardive dyskinesia). it can be effective at any stage of the disease, even when a patient has become bedridden. cogentin often is helpful in patients who have become unresponsive to other agents. cogentin is a powerful anticholinergic agent which is mainly effective in relieving tremor and rigidity. therapy is directed toward control of disturbing symptoms to permit the patient maximum integration of function with minimum discomfort. in non-medicine-induced parkinsonism, partial control of symptoms is usually achieved.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - clomipramine hydrochloride, quantity: 25 mg - tablet, film coated - excipient ingredients: purified talc; maize starch; lactose monohydrate; sodium starch glycollate; magnesium stearate; povidone; titanium dioxide; hypromellose; macrogol 400 - for the treatment o f major depression; obsessive-compulsive disorders and phobias in adults; and cataplexy associated with narcolepsy.

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp and dohme limited - benzatropine mesilate - tablets - 2 milligram

United States - English - NLM (National Library of Medicine)

oak pharmaceuticals, inc. (subsidiary of akorn, inc.) - benztropine mesylate (unii: wmj8tl7510) (benztropine - unii:1nhl2j4x8k) - benztropine mesylate 1 mg in 1 ml - for use as an adjunct in the therapy of all forms of parkinsonism (see dosage and administration). useful also in the control of extrapyramidal disorders (except tardive dyskinesia – see precautions) due to neuroleptic drugs (e.g., phenothiazines). hypersensitivity to any component of cogentin injection. because of its atropine-like side effects, this drug is contraindicated in pediatric patients under three years of age, and should be used with caution in older pediatric patients.

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp and dohme limited - benzatropine mesilate - solution for injection - 1 mg milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp and dohme limited - benzatropine mesilate - solution for injection - 1 mg milligram

Australia - English - Department of Health (Therapeutic Goods Administration)

benztropine mesylate -